Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States

Overview

Journal J Clin Psychiatry

Specialty Psychiatry

Date 2016 Jun 24

PMID 27337416

Citations 120

Authors

Tulshi D Saha

Bradley T Kerridge

Rise B Goldstein

S Patricia Chou

Haitao Zhang

Jeesun Jung

Roger P Pickering

W June Ruan

Sharon M Smith

Boji Huang

Deborah S Hasin

Bridget F Grant

Affiliations

Soon will be listed here.

Abstract

Objective: The authors present 12-month and lifetime prevalence, correlates, psychiatric comorbidity, and treatment of nonmedical prescription opioid use (NMPOU) and DSM-5 NMPOU disorder (NMPOUD).

Methods: Data were derived from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) (N = 36,309).

Results: Prevalences of 12-month and lifetime NMPOU were 4.1% and 11.3%, exceeding rates in the 2001-2002 NESARC (1.8%, 4.7%). Twelve-month and lifetime rates of DSM-5 NMPOUD were 0.9% and 2.1%. NESARC-III DSM-IV NMPOUD rates (0.8%, 2.9%) were greater than those observed in the 2001-2002 NESARC (0.4% and 1.4%). Rates of NMPOU were greater among men, but no sex differential was observed for NMPOUD. Prevalences of NMPOU and NMPOUD were generally greater among 18- to 64-year-old individuals, whites, and Native Americans, and individuals with lower socioeconomic status. Associations were observed between 12-month and lifetime NMPOU and NMPOUD and other drug use disorders, posttraumatic stress disorder, and borderline, schizotypal, and antisocial personality disorders; persistent depression and major depressive disorder (for NMPOU); and bipolar I disorder (for NMPOUD). Only 5.5% and 17.7% of individuals with 12-month NMPOU and NMPOUD were ever treated.

Conclusions: NMPOU and NMPOUD have considerably increased over the past decade, are associated with a broad array of risk factors and comorbidities, and largely go untreated in the United States. More information on the determinants, characteristics, and outcomes of NMPOU and NMPOUD is needed to support evidence-based interventions and prevention.

Citing Articles

Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol.

Khazaee-Pool M, Naghibi S, Pashaei T, Ponnet K Addict Sci Clin Pract. 2024; 19(1):40.

PMID: 38755676 PMC: 11097512. DOI: 10.1186/s13722-024-00472-8.

Does opioid therapy enhance quality of life in patients suffering from chronic non-malignant pain? A systematic review and meta-analysis.

Kraft K, Backmund T, Eberhart L, Schubert A, Dinges H, Hagen M Br J Pain. 2024; 18(3):227-242.

PMID: 38751560 PMC: 11092930. DOI: 10.1177/20494637231216352.

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.

Greenwald M, Wiest K, Haight B, Laffont C, Zhao Y Harm Reduct J. 2023; 20(1):173.

PMID: 38042801 PMC: 10693082. DOI: 10.1186/s12954-023-00906-7.

Remote cognitive behavioral therapy utilizing an in-home virtual reality toolkit (Vx Therapy) reduces pain, anxiety, and depression in patients with chronic cervical and lumbar spondylytic pain: A potential alternative to opioids in multimodal pain....

McGirt M, Holland C, Farber S, Zuckerman S, Spertus M, Theodore N N Am Spine Soc J. 2023; 16:100287.

PMID: 38033880 PMC: 10684389. DOI: 10.1016/j.xnsj.2023.100287.

Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders.

Chamoun K, Mouawad J, Salameh P, Sacre H, Haddad R, Khabbaz L BMC Psychiatry. 2023; 23(1):797.

PMID: 37914993 PMC: 10619223. DOI: 10.1186/s12888-023-05304-8.

References

Martins S, Fenton M, Keyes K, Blanco C, Zhu H, Storr C . Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2011; 42(6):1261-72. PMC: 3513363. DOI: 10.1017/S0033291711002145. View

Amari E, Rehm J, Goldner E, Fischer B . Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry. 2011; 56(8):495-502. DOI: 10.1177/070674371105600808. View

Blanco C, Alderson D, Ogburn E, Grant B, Nunes E, Hatzenbuehler M . Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007; 90(2-3):252-60. DOI: 10.1016/j.drugalcdep.2007.04.005. View

Sullivan M, Howe C . Opioid therapy for chronic pain in the United States: promises and perils. Pain. 2013; 154 Suppl 1:S94-S100. PMC: 4204477. DOI: 10.1016/j.pain.2013.09.009. View

Manchikanti L, Singh A . Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008; 11(2 Suppl):S63-88. View

. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000; 9(3):289-97. DOI: 10.1089/152460900318470. View

Simoni-Wastila L, Yang H . Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother. 2007; 4(4):380-94. DOI: 10.1016/j.amjopharm.2006.10.002. View

Hasin D, Muthuen B, Wisnicki K, Grant B . Validity of the bi-axial dependence concept: a test in the US general population. Addiction. 1994; 89(5):573-9. DOI: 10.1111/j.1360-0443.1994.tb03333.x. View

Pollini R, Banta-Green C, Cuevas-Mota J, Metzner M, Teshale E, Garfein R . Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil. 2013; 2(1):173-180. PMC: 3536052. DOI: 10.2147/SAR.S24800. View

10.

Martell B, OConnor P, Kerns R, Becker W, Morales K, Kosten T . Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007; 146(2):116-27. DOI: 10.7326/0003-4819-146-2-200701160-00006. View

11.

Fleary S, Heffer R, McKyer E . Understanding nonprescription and prescription drug misuse in late adolescence/young adulthood. J Addict. 2014; 2013:709207. PMC: 4007747. DOI: 10.1155/2013/709207. View

12.

Miller M, Sturmer T, Azrael D, Levin R, Solomon D . Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011; 59(3):430-8. PMC: 3371661. DOI: 10.1111/j.1532-5415.2011.03318.x. View

13.

Morasco B, Duckart J, Carr T, Deyo R, Dobscha S . Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010; 151(3):625-632. PMC: 2972371. DOI: 10.1016/j.pain.2010.08.002. View

14.

Hasin D, Stinson F, Ogburn E, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007; 64(7):830-42. DOI: 10.1001/archpsyc.64.7.830. View

15.

Beauchamp G, Winstanley E, Ryan S, Lyons M . Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. Am J Public Health. 2014; 104(11):2023-9. PMC: 4202970. DOI: 10.2105/AJPH.2014.302147. View

16.

Back S, Payne R, Simpson A, Brady K . Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav. 2010; 35(11):1001-7. PMC: 2919630. DOI: 10.1016/j.addbeh.2010.06.018. View

17.

France R . Psychiatric aspects of pain. Clin J Pain. 1989; 5 Suppl 2:S35-41; discussion S41-2. DOI: 10.1097/00002508-198906002-00006. View

18.

Fullerton C, Kim M, Thomas C, Lyman D, Montejano L, Dougherty R . Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv. 2013; 65(2):146-57. DOI: 10.1176/appi.ps.201300235. View

19.

Tragesser S, Jones R, Robinson R, Stutler A, Stewart A . Borderline personality disorder features and risk for prescription opioid use disorders. J Pers Disord. 2013; 27(4):427-41. DOI: 10.1521/pedi_2013_27_094. View

20.

Novak S, Herman-Stahl M, Flannery B, Zimmerman M . Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug Alcohol Depend. 2008; 100(1-2):63-70. PMC: 2647685. DOI: 10.1016/j.drugalcdep.2008.09.013. View